- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04835259
Efficacy of Topical Antioxidants in Tretment of Photoaging
Efficacy of a Combination of Topical Antioxidants in Tretment of Photoaged Skin:A Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
•Sample size calculation: The sample size was assessed prospectively using Openepi version 3.01 to provide a 80% power to detect a 40-50% difference before and after treatment using either topical antioxidants or retinoids with a significance level of 0.05 (based on the results of a previous clinical trial). Assuming 10% dropout, 30 patients will be recruited in each treatment group.
•Statistical analysis: Data will be collected and recorded on excel data sheet. Data will be tested for normality. Quantitative data will be represented as mean and standard deviation, or median and interquartile range. Qualitative data will be presented as number and percentage. The relevant statistical method will be used for comparison. P value will be considered statistically significant if it is less than 0.05
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: esraa ismail
- Phone Number: 00201000509636
- Email: esraasalah123@yahoo.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult volunteers < 50 years old
- Clinical and dermoscopic features of photoaging.
Exclusion Criteria:
- Genodermatoses associated with photosensitivity.
- Treatment by medications affecting skin aging (eg, topical and systemic retinoids) in the last 6 months prior to enrollment.
- Any recent cosmetic procedures.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Group 1(treatment group)
Topical application of a cream of a combination of antioxidants once daily at night for 6 months Name: Selenium ACE cream (Interpharma UK company, Egypt) Ingredients: Selenium (Selenium amino acid chelate) 0.5% Vitamin C (Sodium ascorbyl phosphate - stay C) %1 Vitamin E (Tocopheryl acetate) % 0.5 Vitamin A (Retinyl palmitate) %1 Emulsifiers ( Ceteareth 20 , Glycerol monostearate , Cetyl alcohol) Emollient(Caprylic capric triglycerides) |
application of a topical agent over the whole face for 6 months
Other Names:
|
|
ACTIVE_COMPARATOR: Group 2 (positive control)
Topical application of a retinoid (tretinoin 0.05%) cream once daily at night for 6 months (Acretin 0.05% cream Jamjoom pharmaceuticals, Egypt)
|
application of a topical agent over the whole face for 6 months
Other Names:
|
|
PLACEBO_COMPARATOR: Group 3 (Negative control)
Topical application of a panthenol cream once daily at night for 6 months (panthenol 2% cream, El Nile company, Egypt)
|
application of a topical agent over the whole face for 6 months
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
change in Dermoscopy photoaging scale
Time Frame: assesed every month for 6 months
|
Dermoscopy photoaging scale (DPAS) is a reliable and valid diagnostic tool that can evaluate photoaged skin quantitatively by the help of objective criteria.
It can be used to evaluate the effect of preventive and therapeutic applications for skin aging.
|
assesed every month for 6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: esraa ismail, Sohag University
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Soh-Med-21-01-10
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Photoaging
-
Dr.dr.Irma Bernadette, SpKK (K)Not yet recruiting
-
University of ManchesterUnknownPhotoagingUnited Kingdom
-
Universitätsklinikum Hamburg-EppendorfRecruiting
-
Integrative Skin Science and ResearchNational Mango BoardNot yet recruiting
-
Bausch Health Americas, Inc.Completed
-
Galderma R&DCompletedPhotoagingUnited States
-
Integrative Skin Science and ResearchSytheon Ltd.Not yet recruitingThe Effects of Zinc Di-(Dibutyryl Lisinate) on Skin Health and the Skin Microbiome in Photoaged SkinPhotoagingUnited States
-
Northwestern UniversityActive, not recruiting
-
Derming SRLCompleted
-
Revision SkincareKGL, Inc.CompletedWrinkle | PhotoagingUnited States
Clinical Trials on Selenium Amino Acid Chelate (Selenium ACE cream)
-
Abbott NutritionCompletedPreterm InfantsUnited States
-
Vanderbilt UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Terminated
-
Instituto Nacional de Ciencias Medicas y Nutricion...Completed
-
Centre Hospitalier de MeauxMinistry of Health, FranceCompleted
-
Texas Tech UniversityNational Cancer Institute (NCI); American Cancer Society, Inc.CompletedArsenical Melanosis | Arsenical Keratosis | Arsenical Cancers | Arsenicosis | Arsenic Exposure | Arsenic Toxicity | Arsenic PoisoningBangladesh
-
Institute of Child HealthCompleted
-
S.LAB (SOLOWAYS)Center of New Medical TechnologiesNot yet recruiting
-
Institut National de la Santé Et de la Recherche...French private agenciesCompleted
-
CHRISTUS HealthPharco PharmaceuticalsNot yet recruiting
-
Daren K. HeylandRWTH Aachen University; Queen's University; biosyn Arzneimittel GmbHActive, not recruitingHeart DiseaseCanada, Germany